Breast Cancer Related Lymphedema BCRL Undiagnosed in 36% of Patients with Lymphedema. 87% of Lymphedema Diagnosed Patients not receiving the Gold Standard of Care.
In a Nov. 2013 study of 450 Breast Cancer Survivors who had symptoms of Lymphedema after Breast Cancer Treatment, 36% had not been diagnosed with Lymphedema by their physician. Of the 64% of Breast Cancer Survivors who were diagnosed with Lymphedema, only 13% received the Gold Standard in Treatment consisting of Complete Decongestive Therapy CDT and Manual Lymph Drainage MLD with Compression Garments, and Remedial Exercises as defined by The National Lymphedema Network in their 2011 Position Statement.
This study at The Medical College of Wisconsin showed that despite very effective interventions for Breast Cancer Related Lymphedema, 87% of those diagnosed did not receive the Gold Standard of Care. It also demonstrated that 160 of 450 Breast Cancer Survivors were not diagnosed with Lymphedema despite symptoms.
Please see our section on Breast Cancer Rehabilitation for current research on Breast Cancer Related Lymphedema, early intervention, prevention, and lymphedema treatment. In the Jan. 2013 edition of Breast, BCRL or Breast Cancer Related Lymphedema was found to be the most common disease/ morbidity associated with Breast Cancer Treatment. Early Intervention with monitoring through measurement and bioimpedance is the most highly recommended way to minimize the occurrence of swelling and to get limb swelling under control fast.
Wyatt Rehab is a World Leader in Lymphedema Treatment and Wyatt uses The Gold Standard Treatment for Lymphedema. Wyatt is thoroughly versed in all procedures and devices and has helped thousand of patients since 2005. Contact Wyatt today if you are receiving Breast Cancer Treatment and have concerns about Lymphedema. Print this referral for your Physician and talk with them today.
